• Upon completion of this learning activity, participants should be able to: describe the history of medical and pharmaceutical practice that accelerated the opioid crisis.
  • Define the goals of the CDC guidelines on opioid prescribing for chronic pain
  • Explain the characteristics of NKTR-181 that make it a novel opioid for the future.


Session date: 
09/13/2017 - 7:00am to 8:00am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Geeta Nagpal, MD